I agree that this site is using cookies. You can find further informations here.
X
Haura, Eric B.
180  results:
OpenAccess-fulltext X
Search for persons X
?
1

MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 ..:

Chen, Nan ; Tyler, Logan C ; Le, Anh T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10762338/.  , 2024
Link: http://www.ncbi.nlm.nih...
 
?
2

Author Correction: Neoadjuvant atezolizumab for resectable ..:

Chaft, Jamie E ; Oezkan, Filiz ; Kris, Mark G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10803254/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mu..:

Cho, Byoung Chul ; Kim, Dong-Wan ; Spira, Alexander I...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579096/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

Surgical results of the Lung Cancer Mutation Consortium 3 t..:

Rusch, Valerie W ; Nicholas, Alan ; Patterson, G. Alexander...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288861/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Amivantamab plus lazertinib in osimertinib-relapsed EGFR -m..:

Cho, Byoung Chul ; Kim, Dong-Wan ; Spira, Alexander I...
Nature Medicine, Vol.29 No.10, pp.2577-2585.  , 2023
Link: https://hdl.handle.net/1..
 
?
6

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cel..:

Park, Keunchil ; Haura, Eric B ; Leighl, Natasha B...
Journal of Clinical Oncology, Vol.39 No.30, pp.3391-3402.  , 2022
Link: https://hdl.handle.net/1..
 
?
7

Integrated Proteomics-Based Physical and Functional Mapping..:

Majumder, Anurima ; Hosseinian, Sina ; Stroud, Mia...
qt4gt10245.  , 2022
Link: https://escholarship.org..
 
?
8

Phase I study of taminadenant (PBF509/NIR178), an adenosine..:

Chiappori, Alberto A ; Creelan, Ben ; Tanvetyanon, Tawee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167697/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

IGF-binding proteins secreted by cancer-associated fibrobla..:

Rix, Lily L. Remsing ; Sumi, Natalia J ; Hu, Qianqian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528501/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Neoadjuvant atezolizumab for resectable non-small cell lung..:

Chaft, Jamie E ; Oezkan, Filiz ; Kris, Mark G...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556329/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

The non-canonical target PARP16 contributes to polypharmaco..:

Palve, Vinayak ; Knezevic, Claire E ; Bejan, Daniel S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782927/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Inhibition of Epidermal Growth Factor Receptor Signaling by..:

Madanayake, Thushara W ; Welsh, Eric A ; Darville, Lancia N.F...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595651/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cel..:

Park, Keunchil ; Haura, Eric B ; Leighl, Natasha B...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791812/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Synthesis and Structural Characterization of a Monocarboxyl..:

Xiao, Tao ; Sun, Luxin ; Zhang, Min...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526398/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Cell-type Specific Adaptive Signaling Responses to KRAS(G12..:

Solanki, Hitendra S ; Welsh, Eric A ; Fang, Bin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940280/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15